|
Boston Globe, July 21, 2004
EDITORIAL: Of elephants and
AIDS
BANGKOK, Thailand -- THE INTERNATIONAL AIDS conference
in this Asian capital last week mobilized scientists,
drug salesmen, activists, politicians, actors,
statesmen, medical doctors, and spin doctors
to deal with a disease that is killing 8,000
people a day. Then one non-AIDS death caught
the attention of the 20,000 delegates: A Bangkok
man was stomped to death by an elephant. First
reports identified the guilty elephant as one
of 20 who had performed in an opening day parade
at the conference center, but it was later
found to have been a different beast. With
AIDS, there is no mistaking what is killing
millions.
More than two decades into the worst pandemic
in 600 years, nothing better demonstrates how
the virus still has the upper hand than the
"3 by 5" goal of the World Health
Organization -- 3 million patients under treatment
with AIDS drugs in developing countries by
2005. With just 400,000 people now being treated,
there is little chance the goal will be reached.
Even if it were, it would be more than matched
by the 5 million new infections every year,
including 40,000 in the United States.
AIDS is winning, and it is just getting started
in India, China, and Russia.
As bleak as the figures are, delegates here pointed
to hopeful developments since the last AIDS
conference in Barcelona in 2002. Late last
year the premier of China, Wen Jiabao, shook
hands with an AIDS patient in a move to bring
the disease out of the shadows in that country.
Earlier in 2003, President Bush pledged $15
billion over five years for international AIDS
assistance.
That single act would have made the president
a hero here if he had sent much of the money
to the Global Fund for AIDS, Malaria, and Tuberculosis.
Instead, most US AIDS money last year went
to bilateral programs in 15 African, Caribbean,
and Asian countries.
Credit to Congress Last year Bush proposed just
$200 million for the Global Fund, a fraction
of Europe's contribution. Congress, to its
credit, appropriated $550 million for it, roughly
one-third of its total receipts. For 2005,
Bush has again called for just $200 million.
Congress should at least match last year's
total.
The Bush administration has also been criticized
for trying to negotiate bilateral trade deals
that stop countries from developing generic
versions of the next generation of antiretroviral
drugs produced by brand-name pharmaceutical
companies to replace ones that the virus becomes
resistant to. US officials also lose some of
the good will that $15 billion should yield
by periodically minimizing the importance of
condoms -- for example, suggesting that condoms
are supportable only for prostitutes or women
forced into sex trafficking. Since the United
States is by far the biggest single donor of
condoms to developing countries -- it will
hand out 550 million this year, far more than
the highest number under President Clinton
-- this is mostly rhetoric to appease Bush's
right-wing base, which would like to see the
United States supporting just abstinence or,
in married couples, fidelity.
In an interview last week, Bush's AIDS coordinator,
Randall Tobias, said, "We're trying to
use every tool that's available." He meant
there is a role for all elements of the "ABC
approach" to AIDS prevention first popularized
in Uganda: abstinence, being faithful, and
condoms.
Abstinence is not a realistic option for a young
woman in sub-Saharan Africa who has been married
off to an older man who engages in risky sex
practices. But UN Secretary General Kofi Annan
in his opening-day address used the word abstain
in calling on men to be more responsible in
their sexual behavior and to free themselves
of cultural stereotypes and expectations about
female subordination in the home.
Dr. Ernest Darkoh, manager of Botswana's AIDS
program, also talked about the failure of health
officials to take on men's role in transmitting
the virus. "I don't hear people saying,
'Do something about the men,' " he said.
More freedom for women Even the ABC approach
is too limited for a virus as frustratingly
invulnerable to a vaccine as HIV has proven
itself. The word vaccine was not even mentioned
during the official opening speeches. Scientists
are said to be five to seven years away from
developing a vaginal microbicide that women
could use to protect themselves from men who
don't heed the message of sexual responsibility
and refuse to use condoms. Beyond that line
of defense, women -- and society at large --
would benefit if more resources were invested
in their education. This would free them from
the economic imperative of early marriage to
older, prosperous men or prostitution, with
the great risk that it carries of HIV infection.
During the conference, these and other issues
were debated against a backdrop of the parading
elephants, young Thai women modeling dresses
made of condoms, and Nelson Mandela speaking
eloquently of the TB that afflicted him in
prison. He called for more funds for treatment
of TB, an opportunistic infection that flourishes
when HIV patients' immune systems are weakened.
In the same exhibition hall where drug maker
Roche touted the virtues of its $16,000-to-$20,000
per year Fuzeon treatment for failing AIDS
patients who have run out of options, a 16-foot
motorized condom blimp floated overhead, advertising
an HIV prevention measure that costs pennies
to manufacture.
There is talk of ending or scaling down the biennial
AIDS conferences. This would be a mistake.
World leaders long ignored this deeply stigmatized
disease, which in its initial stages lies so
quietly that many are unaware they carry the
virus and could be infecting others. There
is much to be gained from so many victims and
fighters of AIDS meeting in loud, and sometimes
rude, circus-like gatherings to confront a
disease that owes much of its lethality to
silence.
<< Boston Globe -- 7/21/04 >>
FAIR USE NOTICE
This
site contains copyrighted material the
use of which has not always been specifically
authorized by the copyright owner. We
are making such material available in
our efforts to advance understanding of
environmental, political, human rights,
economic, democracy, scientific, and social
justice issues, etc. We believe this constitutes
a 'fair use' of any such copyrighted material
as provided for in section 107 of the
US Copyright Law. In accordance with Title
17 U.S.C. Section 107, the material on
this site is distributed without profit
to those who have expressed a prior interest
in receiving the included information
for research and educational purposes.
For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml.
If you wish to use copyrighted material
from this site for purposes of your own
that go beyond 'fair use', you must obtain
permission from the copyright owner.
|